A chimera of green fluorescent protein with gelatinase binding and tumor targeting peptide

Protein Expression and Purification

Volumn 72, Issue 2, 2010, Pages 234-237

  Reunanen, Justus ^a   Ranta, Tanja Maria ^a   Peñate Medina, Oula ^b,d   Suojanen, Juho ^a,c   Sorsa, Timo ^a   Salo, Tuula ^c   Koivunen, Erkki ^a,e   Saris, Per E J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b CTT Cancer Targeting Technologies   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Gelatinases; Green fluorescent protein; Matrix metalloproteinases; Protein expression; Protein purification

Indexed keywords

ESCHERICHIA COLI;

ALANINE; CTTHWGFTLC PEPTIDE; CYCLOPEPTIDE; GELATINASE B; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; IMMOBILIZED PROTEIN;

ACUTE MONOCYTIC LEUKEMIA; AFFINITY CHROMATOGRAPHY; AMINO ACID SUBSTITUTION; ARTICLE; CHEMISTRY; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; TUMOR CELL LINE;

ALANINE; AMINO ACID SUBSTITUTION; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GREEN FLUORESCENT PROTEINS; HUMANS; IMMOBILIZED PROTEINS; LEUKEMIA, MONOCYTIC, ACUTE; MATRIX METALLOPROTEINASE 9; PEPTIDES, CYCLIC; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS;

EID: 77956199560     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.03.023     Document Type: Article

References (22)

1. I.M. Clark, T.E. Swingler, C.L. Sampieri, and D.R. Edwards The regulation of matrix metalloproteinases and their inhibitors Int. J. Biochem. Cell Biol. 40 2008 1362 1378
2. R.G. Rowe, and S.J. Weiss Breaching the basement membrane: who, when and how? Trends Cell Biol. 18 2008 560 574
3. H. Birkedal-Hansen Proteolytic remodeling of extracellular matrix Curr. Opin. Cell Biol. 7 1995 728 735
4. R. Roy, J. Yang, and M.A. Moses Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer J. Clin. Oncol. 27 2009 5287 5297
5. G.R. Dodge, I. Pidoux, and A.R. Poole The degradation of type II collagen in rheumatoid arthritis: an immunoelectron microscopic study Matrix 11 1991 330 338
6. E. Pirilä, P. Maisi, T. Salo, E. Koivunen, and T. Sorsa In vivo localization of gelatinases (MMP-2 and -9) by in situ zymography with a selective gelatinase inhibitor Biochem. Biophys. Res. Commun. 287 2001 766 774
7. S. Curran, and G.I. Murray Matrix metalloproteinases in tumour invasion and metastasis J. Pathol. 189 1999 300 308
8. P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. vonSchalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, and D.A. Cheresh Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 Cell 85 1996 683 693 (Pubitemid 26181048)
9. R. Mazzieri, L. Masiero, L. Zanetta, S. Monea, M. Onisto, S. Garbisa, and P. Mignatti Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants EMBO J. 16 1997 2319 2332
10. M. Toth, D.C. Gervasi, and R. Fridman Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells Cancer Res. 57 1997 3159 3167
11. E. Koivunen, W. Arap, H. Valtanen, A. Rainisalo, O.P. Medina, P. Heikkila, C. Kantor, C.G. Gahmberg, T. Salo, Y.T. Konttinen, T. Sorsa, E. Ruoslahti, and R. Pasqualini Tumor targeting with a selective gelatinase inhibitor Nat. Biotechnol. 17 1999 768 774
12. O.P. Medina, T. Söderlund, L.J. Laakkonen, E.K. Tuominen, E. Koivunen, and P.K. Kinnunen Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro Cancer Res. 61 2001 3978 3985
13. M. Björklund, H. Valtanen, H. Savilahti, and E. Koivunen Use of intein-directed peptide biosynthesis to improve serum stability and bioactivity of a gelatinase inhibitory peptide Comb. Chem. High Throughput Screen. 6 2003 29 35
14. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
15. E. Koivunen, T.M. Ranta, A. Annila, S. Taube, A. Uppala, M. Jokinen, G. van Willigen, E. Ihanus, and C.G. Gahmberg Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides J. Cell Biol. 153 2001 905 916
16. C.G. Gahmberg, L. Valmu, T.J. Hilden, E. Ihanus, L. Tian, H. Nyman, U. Lehto, A. Uppala, T. Ranta, and E. Koivunen Leukocyte cell adhesion interactions T.P. Fleming, Cell-Cell Interactions: A Practical Approach 2002 Oxford University Press New York 93 118
17. I. Shima, Y. Sasaguri, J. Kusukawa, H. Yamana, H. Fujita, T. Kakegawa, and M. Morimatsu Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study Cancer 70 1992 2747 2753
18. H. Nomura, H. Sato, M. Seiki, M. Mai, and Y. Okada Expression of membrane-type matrix metalloproteinase in human gastric carcinomas Cancer Res. 55 1995 3263 3266
19. 2 integrin and proMMP-9 progelatinase in neutrophils J. Immunol. 172 2004 7060 7068
20. M. Stefanidakis, K. Karjalainen, D.E. Jaalouk, C.G. Gahmberg, S. O'Brien, R. Pasqualini, W. Arap, and E. Koivunen Role of leukemia cell invadosome in extramedullary invasion Blood 114 2009 3008 3017
21. P. Heikkilä, J. Suojanen, E. Pirilä, A. Väänä nen, E Koivunen, T. Sorsa, T. Salo, Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides, Int. J. Cancer 118 (2006) 2202-2209.
22. J. Suojanen, T. Sorsa, and T. Salo Tranexamic acid can inhibit tongue squamous cell carcinoma growth invasion in vitro Oral Dis. 15 2009 170 175